Discover how the FDA uses dissolution testing and bioequivalence standards to ensure generic drugs work exactly like brand-name versions, preventing risks like dose-dumping.
Apr 30 2026
The FDA ensures generic drugs are safe and effective through the ANDA process, requiring bioequivalence to brand-name drugs without repeating clinical trials. Generics make up 90% of U.S. prescriptions and save billions annually.
Jan 15 2026